Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Pediatrix Medical (MD) over the last 16 years, with Q3 2025 value amounting to -$7.4 million.

  • Pediatrix Medical's Gains from Investment Securities rose 4585.72% to -$7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$20.1 million, marking a year-over-year decrease of 24792.42%. This contributed to the annual value of $1.4 million for FY2024, which is 7273.62% up from last year.
  • Per Pediatrix Medical's latest filing, its Gains from Investment Securities stood at -$7.4 million for Q3 2025, which was up 4585.72% from -$5.0 million recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Gains from Investment Securities ranged from a high of $64.1 million in Q4 2021 and a low of -$13.6 million during Q3 2024
  • Over the past 5 years, Pediatrix Medical's median Gains from Investment Securities value was -$4.1 million (recorded in 2023), while the average stood at $4.9 million.
  • As far as peak fluctuations go, Pediatrix Medical's Gains from Investment Securities skyrocketed by 1475714.29% in 2021, and later crashed by 51974.79% in 2024.
  • Quarter analysis of 5 years shows Pediatrix Medical's Gains from Investment Securities stood at $64.1 million in 2021, then plummeted by 40.65% to $38.1 million in 2022, then rose by 16.05% to $44.2 million in 2023, then crashed by 107.15% to -$3.2 million in 2024, then crashed by 133.33% to -$7.4 million in 2025.
  • Its Gains from Investment Securities was -$7.4 million in Q3 2025, compared to -$5.0 million in Q2 2025 and -$4.6 million in Q1 2025.